Skip to main content

Advertisement

Log in

HIV-1 progression links with viral genetic variability and subtype, and patient’s HLA type: analysis of a Nairobi-Kenyan cohort

  • Original Investigation
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

Abstract

In a Nairobi-Kenyan cohort of 50 HIV-1 positive patients, we analysed the prevalence of HIV-1 subtypes and human leucocyte antigen (HLA) alleles. From this cohort, 33 patients were selected for the analysis of HIV-1 infection progression markers (i.e. CD4 cell counts and viral loads) and their association with HIV-1 genetic variability and subtype, and patient’s HLA type. HIV-1 gag genetic variability, analysed using bioinformatics tools, showed an inverse relationship with CD4 cell count whereas with viral load that relationship was direct. Certain HLA types and viral subtypes were also found to associate with patients’ viral load. Associations between disease parameters and the genetic makeup of the host and virus may be crucial in determining the outcome of HIV-1 infection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Hewitt EW (2003) The MHC class I antigen presentation pathway: strategies for viral immune evasion. Immunology 110(2):163–169

    Article  CAS  PubMed  Google Scholar 

  2. Arien KK, Vanham G, Arts EJ (2007) Is HIV-1 evolving to a less virulent form in humans? Nat Rev Microbiol 5(2):141–151

    Article  CAS  PubMed  Google Scholar 

  3. Haynes BF, Pantaleo G, Fauci AS (1996) Toward an understanding of the correlates of protective immunity to HIV infection. Science 271(5247):324–328

    Article  CAS  PubMed  Google Scholar 

  4. Kaur G, Mehra N (2009) Genetic determinants of HIV-1 infection and progression to AIDS: immune response genes. Tissue Antigens 74(5):373–385

    Article  CAS  PubMed  Google Scholar 

  5. Khoja S, Ojwang P, Khan S, Okinda N, Harania R, Ali S (2008) Genetic analysis of HIV-1 subtypes in Nairobi, Kenya. PLoS One 3(9):e3191

    Article  PubMed Central  PubMed  Google Scholar 

  6. Reekie J, Gatell JM, Yust I, Bakowska E, Rakhmanova A, Losso M et al (2011) Fatal and nonfatal AIDS and non-AIDS events in HIV-1-positive individuals with high CD4 cell counts according to viral load strata. AIDS 25(18):2259–2268

    Article  PubMed  Google Scholar 

  7. Bettinotti MP, Mitsuishi Y, Bibee K, Lau M, Terasaki PI (1997) Comprehensive method for the typing of HLA-A, B, and C alleles by direct sequencing of PCR products obtained from genomic DNA. J Immunother 20(6):425–430

    Article  CAS  PubMed  Google Scholar 

  8. Robinson J, Mistry K, McWilliam H, Lopez R, Parham P, Marsh SG (2011) The IMGT/HLA database. Nucleic Acids Res 39(Database issue):D1171–D1176

    Google Scholar 

  9. Rose PP, Korber BT (2000) Detecting hypermutations in viral sequences with an emphasis on G → A hypermutation. Bioinformatics 16(4):400–401

    Article  CAS  PubMed  Google Scholar 

  10. Yang OO (2009) Candidate vaccine sequences to represent intra- and inter-clade HIV-1 variation. PLoS One 4(10):e7388

    Article  PubMed Central  PubMed  Google Scholar 

  11. Cao K, Moormann AM, Lyke KE, Masaberg C, Sumba OP, Doumbo OK et al (2004) Differentiation between African populations is evidenced by the diversity of alleles and haplotypes of HLA class I loci. Tissue Antigens 63(4):293–325

    Article  CAS  PubMed  Google Scholar 

  12. Bird TG, Kaul R, Rostron T, Kimani J, Embree J, Dunn PP et al (2002) HLA typing in a Kenyan cohort identifies novel class I alleles that restrict cytotoxic T-cell responses to local HIV-1 clades. AIDS 16(14):1899–1904

    Article  CAS  PubMed  Google Scholar 

  13. Pereyra F, Jia X, McLaren PJ, Telenti A, de Bakker PI, Walker BD et al (2010) The major genetic determinants of HIV-1 control affect HLA class I peptide presentation. Science 330(6010):1551–1557

    Article  PubMed Central  PubMed  Google Scholar 

  14. Carrington M, Nelson GW, Martin MP, Kissner T, Vlahov D, Goedert JJ et al (1999) HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. Science 283(5408):1748–1752

    Article  CAS  PubMed  Google Scholar 

  15. Tang J, Tang S, Lobashevsky E, Myracle AD, Fideli U, Aldrovandi G et al (2002) Favorable and unfavorable HLA class I alleles and haplotypes in Zambians predominantly infected with clade C human immunodeficiency virus type 1. J Virol 76(16):8276–8284

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Trachtenberg E, Korber B, Sollars C, Kepler TB, Hraber PT, Hayes E et al (2003) Advantage of rare HLA supertype in HIV disease progression. Nat Med 9(7):928–935

    Article  CAS  PubMed  Google Scholar 

  17. Kiwanuka N, Robb M, Laeyendecker O, Kigozi G, Wabwire-Mangen F, Makumbi FE et al (2009) HIV-1 viral subtype differences in the rate of CD4+ T-cell decline among HIV seroincident antiretroviral naive persons in Rakai district, Uganda. J Acquir Immune Defic Syndr 54(2):180–184

    Google Scholar 

  18. Baeten JM, Chohan B, Lavreys L, Chohan V, McClelland RS, Certain L et al (2007) HIV-1 subtype D infection is associated with faster disease progression than subtype A in spite of similar plasma HIV-1 loads. J Infect Dis 195(8):1177–1180

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

For this study, Syed Hani Abidi’s training was funded by HIV Research Trust (Scholarship No. HIVRT 10-059).

Conflict of interest

Authors declare no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Syed Ali.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (DOC 56 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abidi, S.H., Shahid, A., Lakhani, L.S. et al. HIV-1 progression links with viral genetic variability and subtype, and patient’s HLA type: analysis of a Nairobi-Kenyan cohort. Med Microbiol Immunol 203, 57–63 (2014). https://doi.org/10.1007/s00430-013-0314-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-013-0314-1

Keywords

Navigation